Nanjing Zenshine Pharmaceuticals Co., Ltd. announced a placement of common shares for gross proceeds of CNY 60 million on September 18, 2023. The transaction will include participation from new investor, Hubei Jumpcan Pharmaceutical Co., Ltd. for 3.40520% stake. CNY 506,693 will be included in the registered capital.